-
1
المؤلفون: Jameel Al-Ghazaly, Leila Al-Gharasi, Yousr Noaman, Gianantonio Rosti, Waled Al-Dubai, Munasser Abdullah
المصدر: Clinical Lymphoma Myeloma and Leukemia. 20:e144-e153
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Yemen, Adolescent, medicine.drug_class, Imatinib treatment, Tyrosine-kinase inhibitor, Medication Adherence, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, Overall survival, medicine, Humans, Hydroxyurea, Longitudinal Studies, Longitudinal cohort, Aged, Aged, 80 and over, business.industry, Myeloid leukemia, Hematology, Middle Aged, Progression-Free Survival, Medication possession ratio, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Major Molecular Response, Imatinib Mesylate, Female, Disease characteristics, business, 030215 immunology